The Effects of Estrogen, Progesterone, and C-Erbb Receptor States on 18f-Fdg Uptake of Primary Breast Cancer Lesions
| dc.contributor.author | Mavi, Ayşe | |
| dc.contributor.author | Çermik, Tevfik F. | |
| dc.contributor.author | Urhan, Muammer | |
| dc.contributor.author | Püskülcü, Halis | |
| dc.contributor.author | Basu, Sandip | |
| dc.contributor.author | Yu, Jian Q. | |
| dc.contributor.author | Zhuang, Hongming | |
| dc.contributor.author | Czerniecki, Brian | |
| dc.contributor.author | Alavi, Abass | |
| dc.coverage.doi | 10.2967/jnumed.106.037440 | |
| dc.date.accessioned | 2016-08-11T12:13:06Z | |
| dc.date.available | 2016-08-11T12:13:06Z | |
| dc.date.issued | 2007 | |
| dc.description.abstract | The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson χ2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, χ2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (χ2 = 71.054, P < 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (χ2 = 13.026, P < 0.01). No relationship was detected between PR and C-erbB-2R states (χ2 = 3.695, P > 0.05). ANOVAs showed that PR state alone (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18F-FDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB-2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. | en_US |
| dc.description.sponsorship | Public Health Services research grant M01-RR00040 | en_US |
| dc.identifier.citation | Mavi, A., Çermik, T. F., Urhan, M., Püskülcü, H., Basu, S., Yu, J. Q., Zhuang, H., Czerniecki, B., and Alavi, A. (2007). The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. Journal of Nuclear Medicine, 48(8), 1266-1272. doi:10.2967/jnumed.106.037440 | en_US |
| dc.identifier.doi | 10.2967/jnumed.106.037440 | |
| dc.identifier.doi | 10.2967/jnumed.106.037440 | en_US |
| dc.identifier.issn | 0161-5505 | |
| dc.identifier.scopus | 2-s2.0-34547773618 | |
| dc.identifier.uri | http://doi.org/10.2967/jnumed.106.037440 | |
| dc.identifier.uri | https://hdl.handle.net/11147/2087 | |
| dc.language.iso | en | en_US |
| dc.publisher | Society of Nuclear Medicine and Molecular Imaging | en_US |
| dc.relation.ispartof | Journal of Nuclear Medicine | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Breast cancer | en_US |
| dc.subject | Estrogen | en_US |
| dc.subject | Interactions between receptors | en_US |
| dc.subject | Progesterone | en_US |
| dc.subject | Correlation analysis | en_US |
| dc.title | The Effects of Estrogen, Progesterone, and C-Erbb Receptor States on 18f-Fdg Uptake of Primary Breast Cancer Lesions | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Püskülcü, Halis | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Computer Engineering | en_US |
| gdc.description.endpage | 1272 | en_US |
| gdc.description.issue | 8 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 1266 | en_US |
| gdc.description.volume | 48 | en_US |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W2147837737 | |
| gdc.identifier.pmid | 17631558 | |
| gdc.identifier.wos | WOS:000248584300023 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | BRONZE | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 13.0 | |
| gdc.oaire.influence | 6.9952564E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Adult | |
| gdc.oaire.keywords | Receptor, ErbB-2 | |
| gdc.oaire.keywords | Correlation analysis | |
| gdc.oaire.keywords | Breast Neoplasms | |
| gdc.oaire.keywords | Middle Aged | |
| gdc.oaire.keywords | Estrogen | |
| gdc.oaire.keywords | Breast cancer | |
| gdc.oaire.keywords | Receptors, Estrogen | |
| gdc.oaire.keywords | Fluorodeoxyglucose F18 | |
| gdc.oaire.keywords | Positron-Emission Tomography | |
| gdc.oaire.keywords | Interactions between receptors | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Female | |
| gdc.oaire.keywords | Radiopharmaceuticals | |
| gdc.oaire.keywords | Receptors, Progesterone | |
| gdc.oaire.keywords | Progesterone | |
| gdc.oaire.keywords | Aged | |
| gdc.oaire.popularity | 8.159282E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 3.13615471 | |
| gdc.openalex.normalizedpercentile | 0.9 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 74 | |
| gdc.plumx.crossrefcites | 45 | |
| gdc.plumx.mendeley | 35 | |
| gdc.plumx.pubmedcites | 32 | |
| gdc.plumx.scopuscites | 75 | |
| gdc.scopus.citedcount | 75 | |
| gdc.wos.citedcount | 72 | |
| local.message.claim | 2022-06-06T14:28:42.078+0300 | * |
| local.message.claim | |rp02964 | * |
| local.message.claim | |submit_approve | * |
| local.message.claim | |dc_contributor_author | * |
| local.message.claim | |None | * |
| relation.isAuthorOfPublication.latestForDiscovery | f3844554-c555-4f40-8a31-c2b1f5f2d3e6 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4014-8abe-a4dfe192da5e |
